(BLX) Foreign Trade Bank of Latin - Ratings and Ratios
Exchange: NYSE •
Country: Panama •
Currency: USD •
Type: Common Stock •
ISIN: PAP169941328
Trade Finance, Syndicated Credits, Letters Of Credit, Guarantees, Leasing
Dividends
| Dividend Yield | 5.56% |
| Yield on Cost 5y | 21.72% |
| Yield CAGR 5y | 15.21% |
| Payout Consistency | 81.9% |
| Payout Ratio | 41.6% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.8% |
| Value at Risk 5%th | 38.7% |
| Relative Tail Risk | -5.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.23 |
| Alpha | 30.56 |
| CAGR/Max DD | 2.31 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.463 |
| Beta | 0.759 |
| Beta Downside | 0.871 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.01% |
| Mean DD | 4.15% |
| Median DD | 3.18% |
Description: BLX Foreign Trade Bank of Latin November 13, 2025
Banco Latinoamericano de Comercio Exterior (BLX) is a Panama-based multinational bank that finances foreign trade and economic integration across Latin America and the Caribbean. It operates two primary segments-Commercial and Treasury-accepts deposits, and provides a suite of credit products including bilateral loans, syndicated facilities, letters of credit, factoring, vendor financing, and leasing, as well as investment-management services.
Key data points to watch: (1) BLX’s loan-to-deposit ratio has hovered around 85% in the last twelve months, indicating a balanced funding profile; (2) its exposure to commodity-linked trade finance means earnings are sensitive to regional export volumes, which have risen ~4% YoY in 2024 amid higher demand for agricultural products; and (3) the bank’s return on equity (ROE) has stabilized near 12% after a 2023 dip, reflecting improving asset quality and tighter risk controls.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of BLX’s risk-adjusted returns and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (222.4m TTM) > 0 and > 6% of Revenue (6% = 49.1m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 13.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -637.7% (prev -598.9%; Δ -38.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 1.07b > Net Income 222.4m (YES >=105%, WARN >=100%) |
| Net Debt (3.56b) to EBITDA (226.5m) ratio: 15.69 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (37.2m) change vs 12m ago 1.21% (target <= -2.0% for YES) |
| Gross Margin 35.90% (prev 50.57%; Δ -14.68pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.84% (prev 7.24%; Δ -0.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.44 (EBITDA TTM 226.5m / Interest Expense TTM 507.6m) >= 6 (WARN >= 3) |
Altman Z'' -2.22
| (A) -0.42 = (Total Current Assets 2.19b - Total Current Liabilities 7.40b) / Total Assets 12.50b |
| (B) 0.07 = Retained Earnings (Balance) 891.3m / Total Assets 12.50b |
| (C) 0.02 = EBIT TTM 222.4m / Avg Total Assets 11.95b |
| (D) 0.15 = Book Value of Equity 1.62b / Total Liabilities 10.85b |
| Total Rating: -2.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 62.31
| 1. Piotroski 4.0pt |
| 2. FCF Yield 33.28% |
| 3. FCF Margin data missing |
| 4. Debt/Equity 2.16 |
| 5. Debt/Ebitda 15.69 |
| 6. ROIC - WACC (= -1.39)% |
| 7. RoE 15.42% |
| 8. Rev. Trend 84.52% |
| 9. EPS Trend 88.02% |
What is the price of BLX shares?
As of December 03, 2025, the stock is trading at USD 45.00 with a total of 115,091 shares traded.
Over the past week, the price has changed by +1.12%, over one month by +5.70%, over three months by -0.48% and over the past year by +38.90%.
Over the past week, the price has changed by +1.12%, over one month by +5.70%, over three months by -0.48% and over the past year by +38.90%.
Is BLX a buy, sell or hold?
Foreign Trade Bank of Latin has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy BLX.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 55.5 | 23.3% |
| Analysts Target Price | 55.5 | 23.3% |
| ValueRay Target Price | 67.4 | 49.8% |
BLX Fundamental Data Overview November 21, 2025
Market Cap USD = 1.63b (1.63b USD * 1.0 USD.USD)
P/E Trailing = 7.3733
P/S = 5.2748
P/B = 0.9913
P/EG = 1.58
Beta = 0.843
Revenue TTM = 817.9m USD
EBIT TTM = 222.4m USD
EBITDA TTM = 226.5m USD
Long Term Debt = 2.34b USD (from longTermDebt, last quarter)
Short Term Debt = 139.4m USD (from shortTermDebt, last quarter)
Debt = 3.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.56b USD (from netDebt column, last quarter)
Enterprise Value = 3.22b USD (1.63b + Debt 3.56b - CCE 1.96b)
Interest Coverage Ratio = 0.44 (Ebit TTM 222.4m / Interest Expense TTM 507.6m)
FCF Yield = 33.28% (FCF TTM 1.07b / Enterprise Value 3.22b)
FCF Margin = 131.1% (FCF TTM 1.07b / Revenue TTM 817.9m)
Net Margin = 27.19% (Net Income TTM 222.4m / Revenue TTM 817.9m)
Gross Margin = 35.90% ((Revenue TTM 817.9m - Cost of Revenue TTM 524.3m) / Revenue TTM)
Gross Margin QoQ = 36.50% (prev 39.23%)
Tobins Q-Ratio = 0.26 (Enterprise Value 3.22b / Total Assets 12.50b)
Interest Expense / Debt = 3.55% (Interest Expense 126.3m / Debt 3.56b)
Taxrate = 21.0% (US default 21%)
NOPAT = 175.7m (EBIT 222.4m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.16 (Debt 3.56b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 15.69 (Net Debt 3.56b / EBITDA 226.5m)
Debt / FCF = 3.31 (Net Debt 3.56b / FCF TTM 1.07b)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 222.4m / Total Assets 12.50b)
RoE = 15.42% (Net Income TTM 222.4m / Total Stockholder Equity 1.44b)
RoCE = 5.88% (EBIT 222.4m / Capital Employed (Equity 1.44b + L.T.Debt 2.34b))
RoIC = 3.30% (NOPAT 175.7m / Invested Capital 5.33b)
WACC = 4.69% (E(1.63b)/V(5.18b) * Re(8.81%) + D(3.56b)/V(5.18b) * Rd(3.55%) * (1-Tc(0.21)))
Discount Rate = 8.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 67.06% ; FCFE base≈1.07b ; Y1≈704.2m ; Y5≈322.0m
Fair Price DCF = 194.2 (DCF Value 5.58b / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 88.02 | EPS CAGR: 30.76% | SUE: 4.0 | # QB: 5
Revenue Correlation: 84.52 | Revenue CAGR: 66.98% | SUE: 4.0 | # QB: 9
EPS next Year (2026-12-31): EPS=6.67 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+7.6% | Growth Revenue=+6.6%
P/E Trailing = 7.3733
P/S = 5.2748
P/B = 0.9913
P/EG = 1.58
Beta = 0.843
Revenue TTM = 817.9m USD
EBIT TTM = 222.4m USD
EBITDA TTM = 226.5m USD
Long Term Debt = 2.34b USD (from longTermDebt, last quarter)
Short Term Debt = 139.4m USD (from shortTermDebt, last quarter)
Debt = 3.56b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.56b USD (from netDebt column, last quarter)
Enterprise Value = 3.22b USD (1.63b + Debt 3.56b - CCE 1.96b)
Interest Coverage Ratio = 0.44 (Ebit TTM 222.4m / Interest Expense TTM 507.6m)
FCF Yield = 33.28% (FCF TTM 1.07b / Enterprise Value 3.22b)
FCF Margin = 131.1% (FCF TTM 1.07b / Revenue TTM 817.9m)
Net Margin = 27.19% (Net Income TTM 222.4m / Revenue TTM 817.9m)
Gross Margin = 35.90% ((Revenue TTM 817.9m - Cost of Revenue TTM 524.3m) / Revenue TTM)
Gross Margin QoQ = 36.50% (prev 39.23%)
Tobins Q-Ratio = 0.26 (Enterprise Value 3.22b / Total Assets 12.50b)
Interest Expense / Debt = 3.55% (Interest Expense 126.3m / Debt 3.56b)
Taxrate = 21.0% (US default 21%)
NOPAT = 175.7m (EBIT 222.4m * (1 - 21.00%))
Current Ratio = 0.30 (Total Current Assets 2.19b / Total Current Liabilities 7.40b)
Debt / Equity = 2.16 (Debt 3.56b / totalStockholderEquity, last quarter 1.65b)
Debt / EBITDA = 15.69 (Net Debt 3.56b / EBITDA 226.5m)
Debt / FCF = 3.31 (Net Debt 3.56b / FCF TTM 1.07b)
Total Stockholder Equity = 1.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.78% (Net Income 222.4m / Total Assets 12.50b)
RoE = 15.42% (Net Income TTM 222.4m / Total Stockholder Equity 1.44b)
RoCE = 5.88% (EBIT 222.4m / Capital Employed (Equity 1.44b + L.T.Debt 2.34b))
RoIC = 3.30% (NOPAT 175.7m / Invested Capital 5.33b)
WACC = 4.69% (E(1.63b)/V(5.18b) * Re(8.81%) + D(3.56b)/V(5.18b) * Rd(3.55%) * (1-Tc(0.21)))
Discount Rate = 8.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 67.06% ; FCFE base≈1.07b ; Y1≈704.2m ; Y5≈322.0m
Fair Price DCF = 194.2 (DCF Value 5.58b / Shares Outstanding 28.7m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 88.02 | EPS CAGR: 30.76% | SUE: 4.0 | # QB: 5
Revenue Correlation: 84.52 | Revenue CAGR: 66.98% | SUE: 4.0 | # QB: 9
EPS next Year (2026-12-31): EPS=6.67 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+7.6% | Growth Revenue=+6.6%
Additional Sources for BLX Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle